Prime Capital Investment Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1731446 OVERLAND PARK, KS

Position in REGN

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$10,752,058

+$885,244 QoQ

Shares Held

13,916

+8.9% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Prime Capital Investment Advisors, LLC holds $14,447,509 across 15 Biotechnology names. REGN ranks #1 (74.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	13,916	$10,752,058
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,334	$1,042,224
3	ARWR	Arrowhead Pharmaceuticals, Inc.	15,826	$992,290
4	VKTX	Viking Therapeutics, Inc.	11,343	$369,101
5	IONS	Ionis Pharmaceuticals Inc	3,971	$298,182
6	IMTX	Immatics N.V.	30,000	$295,200
7	MRNA	Moderna, Inc.	4,639	$235,661
8	IBRX	ImmunityBio, Inc.	18,870	$144,732

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,752,058	13,916	+8.9%	Shares	Sole	2026-05-08
2025-12-31	$9,866,814	12,783	+2.5%	Shares	Sole	2026-01-21
2025-09-30	$7,013,755	12,474	+1852.1%	Shares	Sole	2025-11-05
2025-06-30	$335,475	639	-41.6%	Shares	Sole	2025-07-23
2025-03-31	$694,481	1,095	+119.4%	Shares	Sole	2025-05-13
2024-12-31	$355,452	499	-61.6%	Shares	Sole	2025-02-12
2024-09-30	$1,364,509	1,298	+1.5%	Shares	Sole	2024-11-05
2024-06-30	$1,344,267	1,279	-12.4%	Shares	Sole	2024-08-09
2024-03-31	$1,405,235	1,460	+71.6%	Shares	Sole	2024-05-15
2023-12-31	$747,424	851	+35.5%	Shares	Sole	2024-01-24
2023-09-30	$516,818	628	+18.5%	Shares	Sole	2023-11-09
2023-06-30	$380,826	530	+10500.0%	Shares	Sole	2023-08-08
2021-03-31	$2,365	5	—	Shares	Sole	2021-05-07
No filing history on record for this holder in this stock.